Nanomedicine: Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases

This volume in the Methods in Enzymology series comprehensively covers Cancer, Cardiovascular and the central nervous system of Nanomedicine. With an international board of authors, this volume is split into sections that cover subjects such as Diabetes and nanotechnology as potential therapy, Nanomedicines for inflammatory diseases, and Development and use of ceramide nanoliposomes in cancer.

Comprehensively covers cancer and the cardiovascular and central nervous systems of nanomedicineAn international board of authorsSplit into sections that cover subjects such as diabetes and nanotechnology as potential therapy, nanomedicines for inflammatory diseases, and the development and use of ceramide nanoliposomes in cancer

1. Preparation, characterization, and cellular associations of silicon logic-embedded vectors
2. Post-formulation peptide drug loading of nanostructures
3. Application of mesoporous silica nanoparticles in intracellular drug delivery
4. Multifunctional anticancer nanomedicine based on a magnetically responsive cyanoacrylate polymer
5. Development and Use of Ceramide Nanoliposomes in Cancer
6. Multistage nanoparticles for improved delivery into tumor tissue
7. Mitochondria-specific Nanocarriers for Improving the Pro-apoptotic Activity of Small Molecules
8. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles
9. Peptide nanofiber scaffold for brain tissue reconstruction
10. Detection and Treatment of Intravascular Thrombi with Magnetofluorescent Nanoparticles
11. Imaging the efficacy of anti-inflammatory liposomes in a rabbit model of atherosclerosis by non-invasive imaging
12. Lipid Nanoparticles For Drug Targeting To The Brain
13. Transport Of A Caspase Inhibitor Across The Blood Brain Barrier By Chitosan Nanoparticles
14. Nanotechnology As A Promising Strategy For Alternative Routes Of Insulin Delivery
15. Chitosan-coated solid lipid nanoparticles for insulin delivery
16. Peptide nanomedicines for treatment of acute lung injury
17. Nanoparticle-mediated treatment of pulmonary arterial hypertension
18. Nanomedicines for Inflammatory Diseases
19. Polymeric nanoparticles for the selective therapy of inflammatory bowel disease